| Full Name | Mary Cutchin |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 212 3rd St, Cheraw, South Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629183959 | NPI | - | NPPES |
| MW0021 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | APN381 (South Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mary Cutchin, 212 3rd St, Cheraw, SC 29520-2648 Ph: () - | Mary Cutchin, 212 3rd St, Cheraw, SC 29520-2648 Ph: (843) 537-0961 |
News Archive
The Cochrane Collaboration, the international not-for-profit organization that produces systematic reviews of healthcare evidence and the largest database of randomized controlled trials; and John Wiley & Sons, Inc., a global provider of content and workflow solutions in the areas of scientific, technical, medical, and scholarly research, professional development, and education, today announced that they have renewed and redefined their partnership to publish The Cochrane Library from February 2013.
A research team at the University of North Carolina at Chapel Hill's Gillings School of Global Public Health found that a well-known gene variant linked to Type 2 diabetes, called transcription Factor-7 like 2 gene, may also predispose someone to being leaner, or having a lower body weight.
K. Hovnanian Children's Hospital at Jersey Shore University Medical Center introduces Meridian Dentistry for Children, a specialized, full-service, dental practice for infants, children and adolescents in a child-friendly, caring environment.
Investigators report that torcetrapib, a drug that substantially raises high-density lipoprotein cholesterol or HDL (the "good" cholesterol), did not slow the progression of plaque buildup in the coronary arteries as measured using an ultrasound probe (IVUS).
A new patient protocol for aggressive and recurrent lymphoma that combines intensive chemotherapy and radioimmunotherapy (RIT) may become the most powerful cancer-killing therapy available, with the hope that patients' lymphoma can be eradicated as they prepare for bone marrow transplant, say researchers at the 2013 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging.
› Verified 6 days ago